Page 1 of Clinical Trials for Patients with resected pancreatic cancer, 168 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Terminated
A Study Evaluating Gemcitabine Plus Bosutinib for Patients With Resected Pancreatic Cancer
Last Updated: April 3, 2012
Condition(s): Pancreatic Cancer
2
Terminated
A Phase II Study of Gemcitabine and Erlotinib As Adjuvant Therapy In Patients With Resected Pancreatic Cancer
Last Updated: January 6, 2012
Condition(s): Pancreatic Cancer
3
Completed
Adjuvant Gemcitabine and Cisplatin Followed by Chemoradiation for Resected Pancreatic Cancer
Last Updated: July 15, 2011
Condition(s): Pancreatic Cancer
4
Completed
Adjuvant Chemoradiotherapy and Interferon Alfa in Treating Patients With Resected Pancreatic Cancer
Last Updated: November 24, 2010
Condition(s): Pancreatic Cancer
5
Active, not recruiting
Gemcitabine and Bevacizumab in Treating Patients With Pancreatic Cancer That Has Been Completely Removed By Surgery
Last Updated: February 6, 2009
Condition(s): Pancreatic Cancer
6
Recruiting
A Study of Gemzar, Taxotere, and Xeloda for Adjuvant Pancreatic Cancer
Last Updated: October 28, 2011
Condition(s): Pancreatic Cancer
7
Recruiting
Adjuvant Versus Neoadjuvant Plus Adjuvant Chemotherapy in Resectable Pancreatic Cancer
Last Updated: March 10, 2011
Condition(s): Pancreatic Cancer
8
Completed
Gemcitabine, Oxaliplatin and Radiotherapy in Treating Patients With Completely Resected Pancreatic Cancer
Last Updated: October 18, 2007
Condition(s): Pancreatic Neoplasms
9
Active, not recruiting
Vaccine Therapy in Treating Patients With Resected or Locally Advanced Unresectable Pancreatic Cancer
Last Updated: July 29, 2009
Condition(s): Pancreatic Cancer
10
Recruiting
Postoperative Proton Radiotherapy With Chemo for Pancreatic Cancer
Last Updated: March 9, 2012
Condition(s): Pancreatic Cancer
11
Recruiting
Dasatinib and Gemcitabine Hydrochloride or Gemcitabine Hydrochloride Alone in Treating Patients With Pancreatic Cancer Previously Treated With Surgery
Last Updated: March 23, 2011
Condition(s): Acinar Cell Carcinoma of Pancreas; Duct Cell Adenocarcinoma of the Pancreas; Pancreatic Carcinoma Recurrent; Stage IA Pancreatic Cancer; Stage IB Pancreatic Cancer; Stage IIA Pancreatic Cancer; Stage IIB Pancreatic Cancer; Pancreatic Carcinoma Stage III
12
Completed
Vaccine Therapy in Treating Patients With Stage I or Stage II Pancreatic Cancer
Last Updated: December 2, 2009
Condition(s): Pancreatic Cancer
13
Completed
Chemotherapy, Interferon Alfa, and Radiation Therapy in Treating Patients Who Have Undergone Surgery For Pancreatic Cancer
Last Updated: February 13, 2012
Condition(s): Pancreatic Cancer
14
Not yet recruiting
Pancreatic Tumor Cell Vaccine (GVAX), Low Dose Cyclophosphamide, Fractionated Stereotactic Body Radiation Therapy (SBRT), and FOLFIRINOX Chemotherapy in Patients With Resected Adenocarcinoma of the Pancreas
Last Updated: May 9, 2012
Condition(s): Pancreatic Cancer
15
Completed
Vaccine Therapy Combined With Adjuvant Chemoradiotherapy in Treating Patients With Resected Stage I or Stage II Adenocarcinoma (Cancer) of the Pancreas
Last Updated: September 8, 2011
Condition(s): Pancreatic Cancer
16
Completed
Safety and Efficacy Therapy of Gemcitabine and Erbitux® to R0 or R1 Resected Pancreatic Cancer
Last Updated: February 1, 2012
Condition(s): Adenocarcinoma
17
Active, not recruiting
Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer
Last Updated: September 11, 2010
Condition(s): Pancreatic Cancer
18
Withdrawn
Gemcitabine and CT-011 for Resected Pancreatic Cancer
Last Updated: March 15, 2012
Condition(s): Pancreatic Neoplasms; Cancer of the Pancreas; Neoplasms Pancreatic; Pancreatic Cancer; Pancreas Cancer
19
Recruiting
Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed By the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed By Surgery
Last Updated: May 24, 2012
Condition(s): Pancreatic Cancer
20
Completed
Vaccine Treatment for Surgically Resected Pancreatic Cancer
Last Updated: September 25, 2009
Condition(s): Pancreatic Cancer

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Patients+with+resected+pancreatic+cancer

Page 1 of Clinical Trials for Patients with resected pancreatic cancer, 168 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About